Richard M. Rutstein

faculty photo
Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
The Children's Hospital of Philadelphia
Room 12NW60
Department of General Pediatrics
34th & Civic Center Blvd.
Philadelphia, PA 19104
Office: 215-590-1466
Education:
B.A. (Honors-PreMed)
University of Massachusetts, 1974.
M.D.
Albert Einstein College of Medicine, 1977.
Permanent link
 

Description of Itmat Expertise

Dr. Rutstein's HIV-related clinical research involves multiple phase I and II protocols of new anti-retroviral agents. In addition, he has led multiple clinical research efforts describing HIV related illness, drug effect, survival, etc. Dr. Rutstein has a free standing clinical database of all patient visits, and maintains a specimen repository.

Selected Publications

Chun RF, Liu NQ, Lee T, Schall JI, Denburg MR, Rutstein RM, Adams JS, Zemel BS, Stallings VA, Hewison M: Vitamin D supplementation and antibacterial immune responses in adolescents and young adults with HIV/AIDS. J Steroid Biochem Mol Biol. 148: 290-297, Apr 2015.

Agwu AL, Lee L, Fleishman JA, Voss C, Yehia BR, Althoff KN, Rutstein R, Mathews WC, Nijhawan A, Moore RD, Gaur AH, Gebo KA: Aging and Loss to Follow-up Among Youth Living With Human Immunodeficiency Virus in the HIV Research Network. J Adolesc Health 56(3): 345-51, Mar 2015.

Steenhoo AP, Schall JI, Samuel J, Seme B, Marape M, Ratshaa B, Goercke I, Tolle M, Nnyepi MS, Mazhani L, Zemel BS, Rutstein RM, Stallings VA: Vitamin D3 Supplementation In Batswana Children and Adults with HIV: A Pilot Double Blind Randomized Controlled Trial. PloS One 10(2), Feb 23 2015 Notes: e0117123.

Rustein RM, Volkman KM, Bonda S, Shah SS: Ongoing Maternal-Child Transmission of HIV in an Urban Area, 2003-2012. Hosp Pediatr 5(2): 92-5, Feb 2015.

Stallings VA, Schall JI, Hediger ML, Zemel BS, Tuluc F, Dougherty KA, Samuel JL, Rutstein RM: High-dose Vitamin D3 Supplementation in Children and Young Adults with HIV: A Randomized, Placebo-controlled Trial. Pediatr Infect Dis 34(2): e32-40, Feb 2015.

Rutstein RM, Samson P, Fenton T, Fletcher CV, Kiser JJ, Mefenson LM, Smith E, Graham B, Mathew M, Aldrovani G; PACTG 1020A Study Team.: Long-term Safety and Efficacy of Atazanavir-based Therapy in HIV-infected Infants, Children and Adolescents: The Pediatric AIDS Clinical Trials Group Protocol 1020A. Pediatr Infect Dis J. 34(2): 162-7, Feb 2015.

Crowell CS, Huo Y, Tassiopoulos K, Malee KM, Yogev R, Hazra R, Rutstein RM, Nichols SL, Smith RA, Williams PL, Oleske J, Muller WJ; PACTG 219C Study Team and the Pediatric HIVAIDS Cohort Studty (PHACS): Early viral suppression improves neurocognitive outcomes in HIV-infected children. AIDS 29(3): 295-304, Jan 28 2015.

Lipshultz SE, Williams PL, Zeldow B, Wilkinson JD, Rich KC, van Dyke RB, Seage GR 3rd, Dooley LB, Kaltman JR, Siberry GK, Mofenson LM, Shearer WT, Colan SD, Pediatric HIVAIDS Cohort Study (PHACS): Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers. AIDS 29(1): 91-100, Jan 2 2015.

Lazarus JR, Rutstein R, Lowenthal E: Treatment initiation factors and cognitive outcome in youth with perinatally acquired HIV infection. HIV Med. Page: Epub ahead of print, Jan 21 2015.

Berry SA, Gebo KA, Rutstein RM, Althoff KN, Korthuis PT, Gaur AH, Spector SA, Warford R, Yehia BR, Agwu AL.: Trends in Hospitalizations among Children and Young Adults with Perinatally Acquired HIV. Pediatr Infect Dis J. 33: 488-494, December 2014.

back to top
Last updated: 03/25/2015
The Trustees of the University of Pennsylvania